Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Anthera Pharmaceuticals Inc.

This article was originally published in Start Up

Executive Summary

The founder of Peninsula Pharmaceuticals brought investors huge multiples fast by exploiting trans-Pacific dealmaking opportunities. He's now following the same route with Anthera Pharmaceuticals in hopes of repeating his earlier success.

You may also be interested in...



In Inflammation, the Indication's the Thing

With a host of drugs on the market for large inflammatory disease indications like rheumatoid arthritis, start-ups are finding niches elsewhere.

Start-Up Previews (5/07)

A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile group: In Inflammation, the Indication's the Thing, features profiles of Anthera Pharmaceuticals, Logical Therapeutics, Opsona Therapeutics and VLST Corp.. Plus these Start-Ups Across Health Care: Biodesy, Magenta Medical and NuLens.

In Inflammation, the Indication's the Thing

With a host of drugs on the market for large inflammatory disease indications like rheumatoid arthritis, start-ups are finding niches elsewhere.

Related Content

Topics

Related Companies

Related Deals

UsernamePublicRestriction

Register

SC091398

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel